Mark Fry to lead Oxyphen's North American expansion

07-Dec-2006

Oxyphen AG announced that it has signed a sales and marketing agreement with Mark Fry to increase market penetration in North America. Fry will support Oxyphen's ongoing expansion efforts in North America to increase the technology and manufacturing leadership position and to serve the OEM opportunities for track-etched membrane applications. Targeted market segments are in drug discovery, diagnostics, rapid microbiology, drug delivery and bioprocess.

According to Oxyphen, Mark Fry has a broad range of sales, marketing and management experience with several leading life science and diagnostic companies. Mr. Fry's most recent experience was with Whatman Ltd. as Director of OEM Sales in North America. He also served in various sales and marketing roles with Johnson & Johnson, Kodak, Amersham and Ventana Medical Systems. Mr. Fry began his career as a Naval Flight Officer in the United States Navy. Mr. Fry's academic accomplishments include a BSc in biochemistry.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances

See the theme worlds for related content